Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
Mumbai Local Train Update: Special Traffic & Power Blocks On Panvel–Kalamboli For DFCC Project Girder Launch At Kalamboli
Navi Mumbai Civic Polls 2026: Criminal Case Filed Against Shiv Sena (Shinde Faction) Candidates Over Alleged Assault In Airoli
Indian Railways’ 52 Weeks, 52 Reforms: Minister Ashwini Vaishnaw Leads Passenger-Centric Transformation Workshop
Bollywood Celebrities Turn Out In Large Numbers To Vote In BMC Elections | VIDEO
(With inputs from PTI)
